Polymorphism Of Detoxification Genes And Predisposition To The Development Of Parkinson’s Disease In Uzbek Individuals

Khanifa Khalimova, Malika Raimova, Rustam Matmurodov, Khurshidakhon Rasulova, Amina Burnasheva, Yekaterina Jmirko, Rustam Mukhamedov

Abstract


According to our research, Uzbek individuals with Parkinson’s disease have high prevalence of 0/0 polymorphisms of GSTT1 and GSTM1 genes, as well as combinations of GSTT1 (0/0)/GSTM1/(0/0) genotypes. These mutations are associated with an earlier debut of the disease, its mixed form, and rapid rate of progression. Determination of mutations in GSTT1 and GSTM1 genes of xenobiotic detoxification in patients with Parkinson’s disease confirms multifactorial nature of this pathology and the role of the influence of various external factors in the modification of clinical signs of disease and its prognosis.


Keywords


Parkinskon’s Disease , GSTT1 and GSTM1 Genes.

Full Text:

PDF

References


Belin, A.C., Westerlund, M., 2008. “Parkinson’s disease: a genetic perspective”, FEBS J., Vol. 275 (7), pp. 1377-1383.

Defebvre, L. 2010. “Parkinson’s disease: role of genetic and environment factors. Involvement in everyday clinical practice”, Rev. Neurol. (Paris), Vol. 166 (10), pp. 764-769.

Dick, F.D., De Palma, G., Ahmadi, A. et al.., 2007. “Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study”, Occup. Environ. Med., Vol. 64 (10), pp. 666-672.

Firestone, J.A., Smith-Weller, T., Franklin, G. et al., 2005. “Pesticides and risk of Parkinson’s disease: a population-based case-control study”, Arch. Neurol., pp. 6291-6295.

Gilyazova, I.R., 2004. “Molecular-genetic study of Parkinson’s disease in Bashkortostan”, Synopsis of PhD dissertation, in Russian, Ufa, Bashkortostan, 158 p.

Hicks, A.A., Petursson, H., Jonsson, T., et al., 2002. “A susceptibility gene for late-onset idiopathic Parkinson’s disease”, Ann. Neurol., Vol. 52 (5), pp. 549-555.

Illarioshkin, S.N., 2006. “Parkinsonism with early onset”, [Atmosfera. Nervniye Bolezni], in Russian, No.3, pp. 14-20.

Kay, D.M., Factor, S.A., Samii, A. et al., 2008. “Genetic association between alpha-synuclein and idiopathic Parkinson’s disease”, Am. J. Med. Genet. B Neuropsychiatr. Genet., Vol. 147B (7), pp. 1222-1230.

Kiyohara, C., Miyake, Y., Koyanagi, M., Fujimoto, T. et al., 2010. “GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population”, Parkinsonism Relat. Disord., Vol. 16 (7), pp. 447-452.

Lai, B., Marion, S.A., Teschke, K. et al., 2002. “Occupational and environmental risk factors for Parkinson’s disease”, Parkinsonism Relat. Disord., Vol. 16 (7), pp. 8297-8309.

Lesage, S., Brice, A., 2009. “Parkinson’s disease: from monogenic forms to genetic susceptibility factors”, Hum. Mol. Genet., Vol. 18 (R1), pp. R48-R59.

Mata, I.F., Ross, O.A., Kachergus, J. et al., 2006. “LRRK2 mutations are a common cause of Parkinson’s disease in Spain”, Eur. J. Neurol., Vol. 13 (4), pp. 391-394.

Mata, I., Samii, A., Factor, S. et al., 2009. “Variation in the alpha-synuclein gene, independent of REPI, modifies risk for Parkinson’s disease», Neurology, Vol. 72 (11), pp. A393-A394.

Orr-Urtreger, A., Shifrin, C., Rozovski, U., et al., 2007. “The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?”, Neurology, Vol. 69 (16), pp. 1595-1602.

Paisan-Ruiz, C., 2009. “LRRK2 gene variation and its contribution to Parkinson disease”, Hum. Mutat., Vol. 30 (8), pp. 1153-1160.

Pankratz, N., Wilk, J.B., Latourelle, J.C., et al., 2009. “Genomewide association study for susceptibility genes contributing to familial Parkinson disease”, Hum. Genet., Vol. 124 (6), pp. 593-605.

Peng, J., Oo, M.L., Andersen, J.K., 2010. “Synergistic effects of environmental risk factors and gene mutations in Parkinson’s disease accelerate age-related neurodegeneration”, J. Neurochem., Vol. 115 (6), pp. 1363-1373.

Sanyal, J., Chakraborty, D.P., Sarkar, B., Banerjee, T.K. et al., 2010. “Environmental and familial risk factors of Parkinson’s disease: case-control study”, Can. J. Neurol. Sci., Vol. 37 (5), pp. 637-642.

Satake, W., Nakabayashi, Y., Mizuta, I., et al., 2009. “Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease”, Nat. Genet., Vol. 41 (12), pp. 1303-1307.

Simon-Sanchez, J., Schulte, C., Bras, J.M. et al., 2009. “Genome-wide association study reveals genetic risk underlying Parkinson’s disease”, Nat. Genet., Vol. 41 (12), pp. 1308-1312.

Schuurman, A.G., van den Akker, M., Ensinck, K.T. et al., 2002. “Increased risk of Parkinson’s disease after depression: a retrospective cohort study”, Neurology, Vol. 58, pp. 1501-1504.

Vance, J.M., Ali, S., Bradley, W.G., Singer, C., Di Monte, D.A., 2010. “Gene-environment interactions in Parkinson’s disease and other forms of parkinsonism”, Neurotoxicology, Vol. 31 (5), pp. 598-602.

Zagorovskaya, T.B., Illarioshkin, S.N., Slonimsky, P.A. et al., 2008. “Clinical and genetic analysis of juvenile parkinsonism in Russia”, [Zhurnal Nevrologii I Psihiatrii], in Russian, No.8, pp. 66-72.




DOI: http://dx.doi.org/10.12955/emhpj.v2i0.342

Refbacks

  • There are currently no refbacks.


Print ISSN 1804-5804, Online ISSN 1804-9702

(c) 2018 CBU,o.p.s.